Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin vs clonazepam for REM sleep behavior disorder in Parkinson's disease
IRCT20170821035819N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin and clonazepam in REM sleep behavior disorder (RBD) (2 arms), sponsored by Tehran University of Medical Sciences. Started Jun 2019; status: completed.
02
Drugs
melatoninclonazepam
03
Conditions
REM sleep behavior disorder (RBD)
Beyond the preview
Go deeper on IRCT20170821035819N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170821035819N3.